Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.

about

Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series).

P2860

Q48035289-67BFC63F-394B-4B04-A959-322A0855D26F Q52731057-95611433-7817-486C-947A-9763D775027B

P2860

Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.

Item

http://www.wikidata.org/entity/Q51550154

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Lipid peroxidation as risk fac ...... hospholipid syndrome patients.

@en

Lipid peroxidation as risk fac ...... hospholipid syndrome patients.

@nl

type

Item

label

Lipid peroxidation as risk fac ...... hospholipid syndrome patients.

@en

Lipid peroxidation as risk fac ...... hospholipid syndrome patients.

@nl

prefLabel

Lipid peroxidation as risk fac ...... hospholipid syndrome patients.

@en

Lipid peroxidation as risk fac ...... hospholipid syndrome patients.

@nl

P1476

Lipid peroxidation as risk fac ...... phospholipid syndrome patients

@en

P2093

B Todic

http://www.w3.org/2001/XMLSchema#string

D Lisulov

http://www.w3.org/2001/XMLSchema#string

D Marisavljevic

http://www.w3.org/2001/XMLSchema#string

J Kotur-Stevuljevic

http://www.w3.org/2001/XMLSchema#string

J Martinovic

http://www.w3.org/2001/XMLSchema#string

L Memon

http://www.w3.org/2001/XMLSchema#string

L Stojanovich

http://www.w3.org/2001/XMLSchema#string

Natasa Stanisavljevic

http://www.w3.org/2001/XMLSchema#string

S Radovanovic

http://www.w3.org/2001/XMLSchema#string

V Dopsaj

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue sulfhydryl groups

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

The 1982 revised criteria for the classification of systemic lupus erythematosus

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.

Infectious origin of the antiphospholipid syndrome.

Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.

Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: Are they early markers of subclinical atherosclerosis?

Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.

Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis.

P304

2485-2493

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-016-3369-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A Djokovic

P577

2016-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27562033

http://www.w3.org/2001/XMLSchema#string

P921

risk factor

Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.

about

P2860

P2860

Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921